Checkpoint Therapeutics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Sep 05, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 05, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
Cynata to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York
Sep 05, 2017 12:01 pm UTC| Business
MELBOURNE, Australia, Sept. 05, 2017 -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), announced today it will be featured as a presenting company at the 19th Annual...
Fortress Biotech to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Sep 05, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 05, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Biotricity FDA Submission Update
Sep 05, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 05, 2017 -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is...
Sep 05, 2017 12:01 pm UTC| Business
BASKING RIDGE, N.J., Sept. 05, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and...
Select Sands Receives Offer to Purchase Its Ownership Position in Comstock Metals
Sep 05, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, Sept. 05, 2017 -- Select Sands Corp. (“Select Sands” or the “Company”) (TSX-V:SNS) (OTC:SLSDF) announces that it has received an offer from SJ Strategic Investments, LLC, Gracetree...
Bio-Path Holdings to Present at the Rodman & Renshaw Annual Healthcare Conference
Sep 05, 2017 12:01 pm UTC| Business
HOUSTON, Sept. 05, 2017 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic...